Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-01-11
2005-01-11
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S025000, C514S360000, C536S017400, C536S017500, C536S017600, C536S017900, C549S315000, C549S408000, C549S553000
Reexamination Certificate
active
06841536
ABSTRACT:
Disclosed is a prodrug of the formula:where A is a sulfur or a selenium, and R is derived from a mono- di- or oligo- saccharide.Also disclosed is a prodrug of the formula:where A is sulfur or selenium, R′ is derived from a sugar and R′ has the formula (CHOH)nCH2OH, where n is 1 to 5, or R′ is an alkyl or aryl group, orR′ is ═O, and the R″ groups may be the same or different and may be hydrogen, alkyl, alkoxy, carboxy.Also disclosed is a conjugate of an antioxidant vitamin and a thiolamine or selenolamine.Also disclosed is a prodrug of the formula;where A is sulfur or selenium, and R′ is derived from a sugar and R′ has the formula (CHOH)nCH2OH, where n is 1 to 5, or R′ is also be an alkyl or aryl group, orR′ is ═O, and R‡is an alkoxy, or an amine group.Also disclosed is a prodrug of the formula:where R is COOH or H, and R′ is derived from a sugar and R′ has the formula (CHOH)nCH2OH,where n is 1 to 5, or R′ is an alkyl or aryl group, or R′ is ═O.
REFERENCES:
patent: 4011221 (1977-03-01), Sakakibara et al.
patent: 4617189 (1986-10-01), Stockel et al.
patent: 4868114 (1989-09-01), Nagasawa et al.
patent: 5578470 (1996-11-01), Kerkenaar et al.
patent: 5667791 (1997-09-01), Hersh et al.
patent: 6340746 (2002-01-01), Roberts et al.
patent: 0 277 688 (1993-10-01), None
patent: WO 9102741 (1991-03-01), None
R. L. Walters et al., “Modulation of Radiation-Induced Apoptosis by Thiolamines” Int. J. Radiat. Biol. 1997, vol. 72, No. 4, 439-448, (published Oct. 1997).
J. L. Robers, et l. “Thiazolidine Prodrugs of Cysteamine and Cysteine and Radioprotective Agents” Radiation Research, 143, 203 (1995).
Carroll, M, et al. “Efficacy of Radio Protective Agents in Preventing Small and Large Bowel Radiation Injury” Dis Colon Rectum, Jul. 1995, pp. 716-722.
J. Roberts, et al. “Chemoprotection Against Cyclophosphamide-Induced Urotoxicity” Anticancer Reasearch 14: 389-396 (1994).
J. Roberts, et al. “Chemoprotection Against Cyclophosphaminde-Induced Urotoxicity: Ribose-Cysteine” Anticancer Research 14: 383 388 (1994).
Rowe, et al. “Protective Effect of Ribcys Following High-Dose Irradiation of the Rectosigmoid” vol. 56, No. 7681-687.
J. Roberts, et al. “Mechanisms of Chemoprotection by Ribcys, A Thiazolidine Prodrug of L-Cysteine” Med.Chem.Res. (1991) 213-219.
J. Roberts, et al. “Time Course for the Elevation of Glutahione in Numerous Organs of L1210-Bearing CDFI Mice Given the L-Cysteine Prodrug, Ribcys” Toxicology Letters, 59(1991) 245-251.
J. Roberts “L-Cysteine Prodrug Protects Against Cyclophasphanimde Urotoxicity Without Compromising Therapeatuc Activity” Cancere Chemother Pharmocal (1191) 28: 166-170.
J. Roberts “Prodrugs of L-Cysteine as Protective Agetns Against Acetaminophen-Induced Hepatotoxicity” Journal of Medicinal Chemistry, 1987, vo. 30, No. 10.
Baran E. and Drabarek, S. “Studies on Synthesis of S-Glycosidic Bond Between Cysteine and Glucose or Galactose”Polish J. Chem.52:941-946, 1978.
Draguet, C. and Renson, M. “Synthese de la Selenazolidine, de N-Alcoylselenazolidines et de Leurs Derives de Substitution en 2”Bull. Soc. Chim. Belges81:279-287, 1972.
Hildesheim et al. “Etude de l'inhibition d'une t-ARN N2-guanine methyl transferase de foie de lapin par des analogues de la S-adenosyl homocysteine”Biochimie54:989-995, 1972.
Käsbeck, L. and Kessler, H. “Synthesis of S-α-D-Glucosylated L-Cysteine—A Novel S-Glycosyl Amino Acid”Liebigs Ann/Recueil165-167, 1997.
Monsigny et al. “Synthèse d'un nouveau type de glycoconjuguè Le thio-β-D-glucopyranoside de la L-cystèine”Carbohydrate Res.59:589-593, 1977.
Roberts et al. “Differential Chemoprotection Against Acetaminophen-Induced Hepatotoxicity by Latentiated L-Cysteines”Chem. Res. Toxicol.Sep. 1998.
Schneider, F. and Geyer, Hans-Ulrich “Verknüpfung von Zuckern mit Aminosäureestern lipophiler Alkohole zu grenzflächenaktiven Zuckerderivaten” Bd 330;182-187, 1963.
Tanaka et al. “WS1279, A Novel Lipopeptide Isolated fromSteptomyces willmoreiBiological Activities”J. Antibiotics46(11):1699-1706, 1993.
Baruchel et al. “In vivo Selective Modulation of Tissue Glutathione in a Rat Mammary Carcinoma Model”Biochem. Pharmacol50(9):1505-1508, 1995.
Bezlepkin et al. “The Prolongation of Survival In Mice by Dietary Antioxidants Depends on their Age by the Start of Feeding this Diet”Mechanisms of Ageing and Development92:227-234, 1996.
Bohm et al. “A Feasibility Study of Cisplatin Administration with Low-Volume Hydration and Glutathione Protecting in the Treatment of Ovarian Carcinoma”Anticancer Res11:1613-1616, 1991.
Cal et al. “Biochemical and Morphological Changes in the Lenses of Selenium and/or Vitamin E Deficient Rats”Biomed. And Environ. Sci.7:109-115 , 1994.
Clark et al. “Effects of Selenium Supplementation for Cancer Prevention in Patients with Carcinoma of the Skin”JAMA276(24):1957-1963, Dec. 25, 1996.
Crary et al. “Potential Clinical Applications for High-Dose Nutritional Antioxidants”Medical Hypotheses13:77-98, 1984.
Dorr, Robert “Chemoprotectants for Cancer Chemotherapy”Seminars in Oncologyvol. 18, No. 1, Suppl 2, pp 48-58, Feb. 1991.
El-Bayourny et al. “Chemoprevention of Cancer by Organoselenium Compounds”J. Cell. Biochem.Supplement 22:92-100, 1995.
Konstantinov et al. “Antitumor, Nephrotoxic and Clastogenic Effect of cis-DDP with DDTC or NAC”Neoplasma41(5):253-258, 1994.
Kumar et al. “Radioprotection by Antioxidant Enzymes and Enzyme Mimetics”Pharmac. Ther.39:309—309, 1988.
Lautermann et al. “Glutathione Protection against Gentamicin Ototoxicity Depends on Nutritional Status”Hearing Research86:15-24, 1995.
Nagasawa et al. “Prodrugs of L-Cysteine as Liver-Protective Agents, 2(RS)-Methylthiazolidine4R-Carboxylic Acid, a Latent Cysteine”J. Med. Chem.25(5):489-491, May 1982.
Steare, SE and Yellon, DM “The Potential for Endogenous Myocardial Antioxidants to Protect the Mycocardium Against Ischaemia-Reperfusion Injury: Refreshing the Parts Exogenous Antioxidants Cannot Reach?”J. Mol. Cell. Cardiol.27:65-74, 1995.
M. Tamba “Role of Thiols in Radioprotection: Radiation Chemical Aspects”J Biosci.44c:857-862, 1989.
Waters et al. “Antimutagenicity Profiles for Some Model Compounds”Mutation Res.238:57-85, 1990.
Cassidy Pamela B.
Dominick Pamela K.
Roberts Jeannette C.
Short Megan D.
Wilmore Britta H.
Needle & Rosenberg PC
Peselev Elli
University of Utah Research Foundation
LandOfFree
Prodrugs and conjugates of thiol- and selenol-containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrugs and conjugates of thiol- and selenol-containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs and conjugates of thiol- and selenol-containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3409522